Physician profile
Mario Nutis
NPI 1588714596
$69,374.29
in general payments reported to CMS, 2019-2025
37 companies · $4,771 in 2025
The $4,771 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $9,053 · 2021: $9,240 · 2022: $6,030 · 2023: $16K · 2024: $5,811 · 2025: $4,771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $8,139 · Food and Beverage: $3,732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,422.50 |
| Travel and Lodging | $8,139.20 |
| Food and Beverage | $3,731.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $37,351.91 | 2019-2025 | Da Vinci Surgical System |
| Astellas Pharma US INC | $14,588.39 | 2023-2025 | Veozah |
| Baxter Healthcare | $5,415.01 | 2019-2024 | Perclot, Tisseel |
| Lumenis, INC | $3,500.00 | 2019-2020 | |
| Acessa Health INC. | $1,928.59 | 2019-2020 | |
| Medtronic, INC. | $1,039.05 | 2024-2025 | Altaviva, V-Loc 180 |
| Boston Scientific Corporation | $912.45 | 2024-2025 | Solyx Sis System, Bulkamid |
| Abbvie INC. | $665.77 | 2019-2023 | |
| Gynesonics, INC. | $532.44 | 2020 | |
| Avion Pharmaceuticals | $485.98 | 2019-2023 | Balcoltra |
| Coloplast Corp | $356.44 | 2021-2023 | Saffron |
| Ethicon US, LLC | $333.64 | 2021-2023 | Enseal, Vicryl, Evarrest |
| Axonics, INC. | $259.11 | 2024 | Bulkamid, Axonics |
| Coopersurgical, INC. | $248.91 | 2021-2025 | Summit Doppler, Supercut Hysterectomy Scissors, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $177.05 | 2019-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $172.65 | 2021-2025 | Nexplanon |
| Shield Therapeutics INC | $137.46 | 2023-2025 | Accrufer |
| Minerva Surgical, INC | $133.31 | 2019-2023 | |
| Exeltis, USA INC. | $131.40 | 2019-2025 | Slynd |
| Pacira Pharmaceuticals Incorporated | $121.87 | 2019 | |
| Medical Device Business Services, INC. | $121.83 | 2025 | Vistaseal |
| Allotrope Medical, INC | $98.50 | 2022 | |
| Genmab U.S., INC. | $95.40 | 2022 | |
| Daiichi Sankyo INC. | $94.19 | 2022 | |
| Vertical Pharmaceuticals, LLC | $79.41 | 2019 | |
| Sage Therapeutics, LLC | $63.48 | 2024-2025 | Zurzuvae |
| Avanos Medical | $59.44 | 2025 | On-Q Pump and Accessories |
| Therapeuticsmd, INC. | $58.73 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $41.34 | 2020-2021 | |
| Mission Pharmacal Company | $35.42 | 2020-2021 | |
| Pfizer INC. | $26.35 | 2021 | |
| Novo Nordisk INC | $24.65 | 2023 | Ozempic |
| Agiliti Surgical, INC. | $20.34 | 2019 | |
| Hologic Sales and Service, LLC | $18.63 | 2020 | |
| Scynexis, INC. | $17.10 | 2022 | |
| Lupin INC. | $14.25 | 2020 | |
| Smith+Nephew, INC. | $13.80 | 2024 | Pico |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Nutis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.